Stockreport

iECURE to Present OTC-HOPE Clinical Trial Data of ECUR-506 in Ornithine Transcarbamylase Deficiency at the European Society of Gene & Cell Therapy Annual Congress and the American Society ...

Precision BioSciences, Inc.  (DTIL) 
Last precision biosciences, inc. earnings: 11/12 07:15 am Check Earnings Report
PDF PHILADELPHIA--(BUSINESS WIRE)--iECURE, Inc., a genome editing company focused on the development of variant-agnostic in vivo targeted gene insertion therapies for th [Read more]